Key Business Approved

1. Audited Financial Results: Approved the audited financial results (consolidated and standalone) for the fourth quarter and financial year ended March 31, 2026.

2. Dividend Recommendation: Recommended a dividend of ₹3.5 per equity share (70% on face value of ₹5 each) for FY 2025-26, subject to shareholder approval.

3. Auditor Appointments: Re-appointed M/s. PricewaterhouseCoopers Services LLP and M/s. Oswal Sunil & Co. Chartered Accountants as Internal Auditors for FY 2026-27.

Financial Results Overview (₹ in lacs, except per share data)

Standalone Performance

  • Q4 FY26 Total Income: ₹45,813.68
  • Q4 FY26 Net Profit: ₹8,062.17
  • FY26 Total Income: ₹1,78,238.25
  • FY26 Net Profit: ₹33,598.49
  • EPS (Basic): Q4 FY26: ₹7.95; FY26: ₹33.15

Consolidated Performance

  • Q4 FY26 Total Income: ₹55,226.79
  • Q4 FY26 Net Profit: ₹6,504.10
  • FY26 Total Income: ₹1,99,534.14
  • FY26 Net Profit: ₹32,072.99
  • EPS (Basic): Q4 FY26: ₹6.54; FY26: ₹31.79

Exceptional Items

An exceptional item of ₹680.40 lacs was recorded in FY26 due to the impact of new Labour Codes (Code on Wages 2019, Industrial Relations Code 2020, Code on Social Security 2020, and Occupational Safety, Health and Working Conditions Code 2020).

Key Financial Metrics

Balance Sheet Highlights (as of March 31, 2026)

Standalone:

  • Total Assets: ₹3,54,994.89 lacs
  • Total Equity: ₹3,05,271.24 lacs
  • Paid-up Equity Capital: ₹5,067.97 lacs

Consolidated:

  • Total Assets: ₹3,91,856.72 lacs
  • Total Equity: ₹3,14,924.32 lacs
  • Non-controlling Interest: ₹4,307.05 lacs

Cash Flow (FY26)

Standalone:

  • Net Cash from Operating Activities: ₹24,519.82 lacs
  • Net Cash Used in Investing Activities: ₹26,783.58 lacs
  • Net Cash from Financing Activities: ₹2,802.72 lacs

Consolidated:

  • Net Cash from Operating Activities: ₹24,637.46 lacs
  • Net Cash Used in Investing Activities: ₹22,538.11 lacs
  • Net Cash from Financing Activities: ₹2,015.14 lacs

Acquisitions and Business Combinations

1. Pendracare Group: Acquired 90% economic rights through RISOR Holding BV. Provisional fair value measurements applied; goodwill recognized represents synergistic benefits. Net cash outflow: ₹14,825.77 lacs.

2. Medistream SA (Citieffe Group): Acquired 100% economic rights. Final acquisition accounting completed; goodwill recognized. Net cash outflow: ₹23,823.77 lacs.

3. Himalayan Mineral Water Private Limited: Resolution plan approved by NCLT Allahabad (Order dated August 12, 2025). Amount deposited: ₹3,316.00 lacs; acquisition pending as of March 31, 2026.

QIP Utilization (as of March 31, 2026)

Proceeds from QIP (₹99,999.98 lacs) utilized as follows:

  • Capital Expenditure: ₹6,198.32 lacs
  • Inorganic Initiatives: ₹25,026.84 lacs
  • General Corporate Purposes: ₹18,877.46 lacs
  • Temporarily Invested: ₹48,427.79 lacs
  • QIP Share Issue Expenses: ₹1,465.61 lacs
  • Bank Balance in QIP Account: ₹3.96 lacs

ESOP Allotment

During FY26, 33,775 equity shares (face value ₹5) were allotted under the Employees Stock Option Scheme 2020 at an exercise price of ₹1,100 per share.

Notes to Financial Results

  • Financial results prepared in accordance with Ind AS.
  • Consolidated results include subsidiaries and associates as listed in Annexure-I.
  • Previous period figures regrouped for consistency.

Meeting Details

Board meeting held on May 25, 2026, from 12:00 PM to 3:00 PM at the registered office in New Delhi.